Inflammation, Immunity, and Metabolism at the Interface of Type 1 and Type 2 Diabetes - May 5�6, 2009
NIDDK Inflammation, Immunity, and Metabolism at the Interface of Type 1 and Type 2 Diabetes - May 5�6, 2009, Hilton Washington DC/Rockville Executive Meeting Center
Home Registration Inflammation, Immunity, and Metabolism at the Interface of Type 1 and Type 2 Diabetes - May 5�6, 2009 Logistics agenda
NIDDK Inflammation, Immunity, and Metabolism at the Interface of Type 1 and Type 2 Diabetes - May 5�6, 2009, Hilton Washington DC/Rockville Executive Meeting Center
 

Purpose of the Workshop:

Diabetes mellitus is a heterogeneous disease that is affected by a wide spectrum of inflammatory reactions. Whereas chronic and destructive inflammation of the pancreatic islets (insulitis) is a defining causal feature of Type 1 diabetes (T1D), low-grade systemic inflammation and activation of innate immunity contribute to the pathogenesis of Type 2 diabetes (T2D). Recent evidence suggests, however, that systemic inflammation and insulin resistance also may contribute to T1D, and the reduced β-cell mass observed in T2D may in part be due to insulitis and enhanced apoptosis. The composition and texture of these innate and adaptive immune responses and the interface with metabolic disturbances determine the inflammatory phenotype observed in the diabetes syndromes. With the aim of guiding the National Institute of Diabetes and Digestive and Kidney Diseases on the state of the art and perspectives within this area of research, the purpose of this workshop is to invite relevant investigators to discuss:
  1. The reciprocal regulation of innate and adaptive immunity, highlighting a possibly significant role in the pathogenesis of diabetes.

  2. Insulin resistance and chronic activation of the Innate Immune System in T2D and T1D, and the contribution to the metabolic derangement that is common to both diseases.

  3. Convergence of the inflammatory and autoimmune processes on the function and survival of the β-cell, and the differences and commonalities between T1D and T2D.

  4. Lessons learned from the investigation of other chronic autoimmune/inflammatory disorders, with an emphasis on how this information might help investigators to understand diabetes pathogenesis and potential treatments.
Co-chairs:

Thomas Mandrup-Poulsen, MD., Ph.D.
Steno Diabetes Center

Diane Mathis, Ph.D., M.Sc.
The Harvard Stem Cell Institute

Jerry Palmer, M.D.
University of Washington

Steven Shoelson, M.D., Ph.D.
Joslin Diabetes Center


For more information, please contact:

NIDDK Meeting Contact:
Guillermo Arreaza-Rub�n, M.D.
Telephone: (301) 594-4724
Email: arreazag@mail.nih.gov

Meeting Logistics Coordinator:
Mary Compton
Telephone: (301) 670-4990
Email: mcompton@scgcorp.com

 
NIDDK Inflammation, Immunity, and Metabolism at the Interface of Type 1 and Type 2 Diabetes - May 5�6, 2009, Hilton Washington DC/Rockville Executive Meeting Center
DHHS NIH NIDDK

Some documents are in various format.
* Documents in PDF format require Adobe Acrobat Reader exit-disclaimer Icon application for viewing.
* Documents in DOC format require MS Word Viewer exit-disclaimer Icon
* Documents in XLS format require Excel Viewer exit-disclaimer Icon.
* Documents in PPT format require PowerPoint Viewer exit-disclaimer Icon.

Contact NIDDK |   Privacy Statement |   Disclaimers |  Freedom of Information Act |  For Staff Only |  Accessibility |  Copyright Status |  Archives Site Map                            

Director: Griffin P. Rodgers, M.D., M.A.C.P
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is part of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services.
 
General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
Phone: 301.496.3583